Variant report
Variant | esv3512786 |
---|---|
Chromosome Location | chr4:120275104-120279402 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs72918504 | chr4:120275130-120275131 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs67050011 | chr4:120275146-120275147 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532171079 | chr4:120275157-120275158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551737168 | chr4:120275188-120275189 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565461070 | chr4:120275193-120275194 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs528141021 | chr4:120275196-120275197 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548384800 | chr4:120275223-120275224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568594644 | chr4:120275263-120275264 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs62320725 | chr4:120275268-120275269 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs11724530 | chr4:120275328-120275329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375352607 | chr4:120275337-120275338 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62320726 | chr4:120275344-120275345 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | mRNA abundance |
13 | rs201551469 | chr4:120275345-120275346 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539868935 | chr4:120275391-120275392 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs369440165 | chr4:120275423-120275424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs573387072 | chr4:120275448-120275449 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs3817230 | chr4:120275499-120275500 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs189061573 | chr4:120275522-120275523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376410002 | chr4:120275561-120275562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs182007833 | chr4:120275575-120275576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs563630924 | chr4:120275620-120275621 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs577037500 | chr4:120275653-120275654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545411614 | chr4:120275654-120275655 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs558883117 | chr4:120275660-120275661 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs56818816 | chr4:120275663-120275664 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
26 | rs547930243 | chr4:120275686-120275687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186392647 | chr4:120275715-120275716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs79319059 | chr4:120275733-120275734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs201322466 | chr4:120275740-120275741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs56811197 | chr4:120275743-120275744 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs62320728 | chr4:120275744-120275745 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs62320729 | chr4:120275746-120275747 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
33 | rs372376956 | chr4:120275748-120275749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs370142056 | chr4:120275749-120275750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs77968117 | chr4:120275765-120275766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs34708009 | chr4:120275766-120275767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200169198 | chr4:120275767-120275768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs540851248 | chr4:120275789-120275790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs13122306 | chr4:120275801-120275802 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
40 | rs79825884 | chr4:120275803-120275804 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs540102183 | chr4:120275812-120275813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189912858 | chr4:120275824-120275825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs6858660 | chr4:120275825-120275826 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs180677006 | chr4:120275834-120275835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114404789 | chr4:120275852-120275853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs575631140 | chr4:120275947-120275948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537274807 | chr4:120275989-120275990 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs28633994 | chr4:120276037-120276038 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
49 | rs577077622 | chr4:120276042-120276043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186378794 | chr4:120276053-120276054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:120269200-120277600 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr4:120269600-120293000 | Weak transcription | Fetal Heart | heart |
3 | chr4:120273800-120275200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr4:120274400-120275200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
5 | chr4:120274400-120275400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr4:120274400-120275400 | Enhancers | NHEK | skin |
7 | chr4:120274800-120275200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr4:120274800-120275400 | Enhancers | HMEC | breast |
9 | chr4:120275000-120275200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
10 | chr4:120275400-120276600 | Weak transcription | HMEC | breast |
11 | chr4:120276800-120277000 | Enhancers | HMEC | breast |
12 | chr4:120276800-120277600 | Enhancers | HSMM | muscle |
13 | chr4:120276800-120278000 | Enhancers | Muscle Satellite Cultured Cells | -- |
14 | chr4:120277000-120277200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
15 | chr4:120277600-120278000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
16 | chr4:120277600-120278000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr4:120277800-120278000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr4:120278000-120278400 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
19 | chr4:120278000-120278400 | Enhancers | Skeletal Muscle Female | skeletal muscle |